ITTO20040760A1 - USE OF A CORTICOSTEROID IN ASSOCIATION WITH OTHER ACTIVE PRINCIPLES FOR THE TREATMENT OF VASCULAR STENOSIS AND THE PREVENTION OF VASCULAR RESTENOSIS - Google Patents

USE OF A CORTICOSTEROID IN ASSOCIATION WITH OTHER ACTIVE PRINCIPLES FOR THE TREATMENT OF VASCULAR STENOSIS AND THE PREVENTION OF VASCULAR RESTENOSIS

Info

Publication number
ITTO20040760A1
ITTO20040760A1 IT000760A ITTO20040760A ITTO20040760A1 IT TO20040760 A1 ITTO20040760 A1 IT TO20040760A1 IT 000760 A IT000760 A IT 000760A IT TO20040760 A ITTO20040760 A IT TO20040760A IT TO20040760 A1 ITTO20040760 A1 IT TO20040760A1
Authority
IT
Italy
Prior art keywords
vascular
corticosteroid
association
prevention
treatment
Prior art date
Application number
IT000760A
Other languages
Italian (it)
Inventor
Flavio Ribichini
Corrado Vassanelli
Original Assignee
Uni Degli Studi Del Piemonte
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Uni Degli Studi Del Piemonte filed Critical Uni Degli Studi Del Piemonte
Priority to IT000760A priority Critical patent/ITTO20040760A1/en
Publication of ITTO20040760A1 publication Critical patent/ITTO20040760A1/en
Priority to BRPI0517983-1A priority patent/BRPI0517983A/en
Priority to RU2007120522/14A priority patent/RU2007120522A/en
Priority to CA002586212A priority patent/CA2586212A1/en
Priority to PCT/IB2005/003271 priority patent/WO2006048736A1/en
Priority to EP05809315A priority patent/EP1814557A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/341—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
IT000760A 2004-11-03 2004-11-03 USE OF A CORTICOSTEROID IN ASSOCIATION WITH OTHER ACTIVE PRINCIPLES FOR THE TREATMENT OF VASCULAR STENOSIS AND THE PREVENTION OF VASCULAR RESTENOSIS ITTO20040760A1 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
IT000760A ITTO20040760A1 (en) 2004-11-03 2004-11-03 USE OF A CORTICOSTEROID IN ASSOCIATION WITH OTHER ACTIVE PRINCIPLES FOR THE TREATMENT OF VASCULAR STENOSIS AND THE PREVENTION OF VASCULAR RESTENOSIS
BRPI0517983-1A BRPI0517983A (en) 2004-11-03 2005-11-02 corticosteroid use in combination with diuretic and antacid for treatment of vascular stenosis and prevention of vascular restenosis
RU2007120522/14A RU2007120522A (en) 2004-11-03 2005-11-02 USE OF A CORTICOSTEROID IN COMBINATION WITH DIURETIC AND ANTACID FOR THE TREATMENT OF VASCULAR STENOSIS AND PREVENTION OF VASCULAR RESTENOSIS
CA002586212A CA2586212A1 (en) 2004-11-03 2005-11-02 Use of a corticosteroid in association with a diuretic and an antacid for the treatment of vascular stenosis and the prevention of vascular restenosis
PCT/IB2005/003271 WO2006048736A1 (en) 2004-11-03 2005-11-02 Use of a corticosteroid in association with a diuretic and an antacid for the treatment of vascular stenosis and the prevention of vascular restenosis
EP05809315A EP1814557A1 (en) 2004-11-03 2005-11-02 Use of a corticosteroid in association with a diuretic and an antacid for the treatment of vascular stenosis and the prevention of vascular restenosis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT000760A ITTO20040760A1 (en) 2004-11-03 2004-11-03 USE OF A CORTICOSTEROID IN ASSOCIATION WITH OTHER ACTIVE PRINCIPLES FOR THE TREATMENT OF VASCULAR STENOSIS AND THE PREVENTION OF VASCULAR RESTENOSIS

Publications (1)

Publication Number Publication Date
ITTO20040760A1 true ITTO20040760A1 (en) 2005-02-03

Family

ID=36051437

Family Applications (1)

Application Number Title Priority Date Filing Date
IT000760A ITTO20040760A1 (en) 2004-11-03 2004-11-03 USE OF A CORTICOSTEROID IN ASSOCIATION WITH OTHER ACTIVE PRINCIPLES FOR THE TREATMENT OF VASCULAR STENOSIS AND THE PREVENTION OF VASCULAR RESTENOSIS

Country Status (6)

Country Link
EP (1) EP1814557A1 (en)
BR (1) BRPI0517983A (en)
CA (1) CA2586212A1 (en)
IT (1) ITTO20040760A1 (en)
RU (1) RU2007120522A (en)
WO (1) WO2006048736A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8324192B2 (en) 2005-11-12 2012-12-04 The Regents Of The University Of California Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
US8497258B2 (en) 2005-11-12 2013-07-30 The Regents Of The University Of California Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
US8679545B2 (en) 2005-11-12 2014-03-25 The Regents Of The University Of California Topical corticosteroids for the treatment of inflammatory diseases of the gastrointestinal tract
US8865692B2 (en) 2007-11-13 2014-10-21 Meritage Pharma, Inc Compositions for the treatment of gastrointestinal inflammation
DK2214679T3 (en) 2007-11-13 2019-05-20 Meritage Pharma Inc CORTICOSTEROID COMPOSITIONS
EP2127639A1 (en) * 2008-05-26 2009-12-02 Universiteit Utrecht Holding B.V. Corticosteroid containing liposomes for treatment of cardiovascular diseases

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6500938B1 (en) * 1998-01-30 2002-12-31 Incyte Genomics, Inc. Composition for the detection of signaling pathway gene expression
AR032316A1 (en) * 2000-04-12 2003-11-05 Novartis Ag USE OF A PHARMACEUTICAL COMPOSITION FOR THE MANUFACTURE OF MEDICINES AND A PHARMACEUTICAL COMPOSITION

Also Published As

Publication number Publication date
EP1814557A1 (en) 2007-08-08
RU2007120522A (en) 2008-12-10
BRPI0517983A (en) 2008-10-21
CA2586212A1 (en) 2006-05-11
WO2006048736A1 (en) 2006-05-11

Similar Documents

Publication Publication Date Title
IL183658A0 (en) Solid dosage form comprising proton pump inhibitor and suspension made thereof
IL178012A0 (en) Diphenyl-indol-2-on compounds and their use in the treatment of cancer
PL1830888T3 (en) Lipid complexes coated with peg and their use
ZAA200501454S (en) Chair bodies and chairs
WO2006097535A3 (en) Peptide agonists of the glucagon family with secretin like activity
DE60238422D1 (en) OPTIMIZED DOSAGE IN PACLITAXELIC STENTS
CA113972S (en) Track for display shelving
ATE553096T1 (en) PYRIDAZINE DERIVATIVES AND THEIR USE AS THERAPEUTIC ACTIVE INGREDIENTS
EE200100405A (en) Use of 3-hydroxy-3-methylglutaryl coenzyme as a reductase inhibitor in the preparation of a medicament for the treatment of diabetic neuropathy
IL183664A0 (en) Rapamycin analogues and the uses thereof in the treatment of neurological, proliferative, and inflammatory disorders
ITRM20050103A1 (en) ASSOCIATION OF ANTAGONISTS OF THE INTERLEUCHINE 6 AND ANTIPROLIFERATIVE DRUGS.
WO2006017822A3 (en) Quinazoline derivatives and their use in the treatment of thrombocythemia
DE602005022995D1 (en) ARYLSULFONES AND ASSOCIATED USES THEREOF
SI1807156T1 (en) New pharmaceutical formulations useful in the treatment of insomnia
DE602004029308D1 (en) Stents and stent delivery systems
ITTO20040760A1 (en) USE OF A CORTICOSTEROID IN ASSOCIATION WITH OTHER ACTIVE PRINCIPLES FOR THE TREATMENT OF VASCULAR STENOSIS AND THE PREVENTION OF VASCULAR RESTENOSIS
EP1726313A4 (en) Drug for preventing and treating arteriosclerosis
WO2007086943A3 (en) Wortmannin conjugates and uses thereof
CA115335S (en) Massage chair
IL162941A0 (en) Carboxamidine derivatives and their use in the treatment of vascular diseases
CA115336S (en) Massage chair
CA115337S (en) Massage chair
ITTO20040460A1 (en) ABSORBENT WEARABLE SANITARY PRODUCTS IN THE WAY OF A PUT AND RELATED MANUFACTURING PROCEDURE.
ITMO20040175A1 (en) DEVICE FOR THE INTRODUCTION AND POSITIONING OF STENTS IN VANGI SANGUGNI.
AU2003244437A1 (en) Quinoxalinones and their use especially in the treatment of cardiovascular diseases